tirzepatide weight loss program telehealth Elevate Health GLP-1 Analysis: vs Semaglutide Access, Compounded Medication Pricing and Prescription Pathways Is Tirzepatide a Game-Changer in

It mimics the action of an incretin hormone, GLP-1 (glucagon-like peptide-1), which is naturally produced in the body after eating

Introduction I, the undersigned, consent to participate in the medically supervised weight loss program that may include the use of Tirzepatide, a glucagon-like peptide-1 (GLP-1) receptor agonist, which may aid in appetite control and weight reduction.Tirzepatide is FDA-approved for the treatment of Type 2 diabetes and may be used off-label for weight loss under medical supervision

Still, the studys authors said additional confirmation is needed, especially in women without diabetes

BMC Cancer 6 , 154 (2006)

Compared to the number of psychiatric AEs reported in 2021 ( n = 935) and 2022 ( n = 893), the psychiatric AEs of GLP-1 RAs reported in Q1 alone in 2023 reached a whopping 411 cases, demonstrating the growing clinical use of GLP-1 RAs